Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: eszopiclone

« Back to Dashboard

Eszopiclone is the generic ingredient in two branded drugs marketed by Dr Reddys Labs Ltd, Glenmark Generics, Lupin Ltd, Mylan Pharms Inc, Orchid Hlthcare, Roxane, Sun Pharma Global, Teva, Wockhardt Ltd, and Sunovion Pharms Inc, and is included in ten NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for eszopiclone. Eleven suppliers are listed for this compound.

Summary for Generic Name: eszopiclone

Tradenames:2
Patents:1
Applicants:10
NDAs:10
Drug Master File Entries: see list20
Suppliers: see list11
Therapeutic Class:Sedatives/Hypnotics

Clinical Trials for: eszopiclone

Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder
Status: Completed Condition: Post-Traumatic Stress Disorders

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics
ESZOPICLONE
eszopiclone
TABLET;ORAL091166Apr 15, 2014RXNo<disabled><disabled>
Teva
ESZOPICLONE
eszopiclone
TABLET;ORAL091169May 23, 2011RXNo<disabled><disabled>
Lupin Ltd
ESZOPICLONE
eszopiclone
TABLET;ORAL091124Sep 13, 2011RXNo<disabled><disabled>
Dr Reddys Labs Ltd
ESZOPICLONE
eszopiclone
TABLET;ORAL091024Apr 15, 2014RXNo<disabled><disabled>
Mylan Pharms Inc
ESZOPICLONE
eszopiclone
TABLET;ORAL091151Mar 26, 2013RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:
Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc